Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FC Patch Low versus EVRA transdermal contraceptive patch trial
2008-007308-27Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2009
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ethinyl estradiol + norelgestromin in contraception (2 arms), sponsored by Bayer. Primary endpoints: Cycle control parameters and Bleeding pattern indices. Started Feb 2009; status: completed.
02
Drugs
ethinyl estradiol + norelgestromin
03
Conditions
contraception
Beyond the preview
Go deeper on 2008-007308-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007308-27.